https://doi.org/10.4081/monaldi.2025.3525
Post-tuberculosis lung disease patients benefit from vaccinations as other respiratory conditions
Published: May 26, 2025
Abstract Views: 61
PDF_EARLY VIEW: 39
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor,
A joint statement of the Italian respiratory, infectious diseases and public health societies has been recently published on the best vaccination strategies in respiratory disease...
Micheletto C, Aliberti S, Andreoni M, et al. Vaccination strategies in respiratory diseases: recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI. Respiration 2025;1-19.
DOI: https://doi.org/10.1159/000544919
Nasiri MJ, Silva DR, Rommasi F, et al. Vaccination in post-tuberculosis lung disease management: a review of the evidence. Pulmonology 2025;31:2416801.
DOI: https://doi.org/10.1016/j.pulmoe.2023.07.002
Silva DR, Santos AP, Visca D, et al. Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease. J Bras Pneumol 2024;49:e20230269.
DOI: https://doi.org/10.36416/1806-3756/e20230269
Inwentarz JS, Migliori GB, Lagrutta L, et al. Recomendaciones para el manejo de la enfermedad pulmonar post tuberculosis. Respirar 2024;16:271-88.
DOI: https://doi.org/10.55720/respirar.16.3.6
Migliori GB, Marx FM, Ambrosino N, et al. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis 2021;25:797-813.
DOI: https://doi.org/10.5588/ijtld.21.0425
WHO. Integrated approach to tuberculosis and lung health: policy brief. Geneva: World Health Organization; 2025. Available from: https://iris.who.int/bitstream/handle/10665/380840/9789240107526-eng.pdf?sequence=1.
Menzies NA, Quaife M, Allwood BW, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health 2021;9:e1679-87.
DOI: https://doi.org/10.1016/S2214-109X(21)00367-3
Zawedde J, Abelman R, Musisi E, et al. Lung function and health-related quality of life among adult patients following pulmonary TB treatment. Int J Tuberc Lung Dis 2024;28:419-26.
DOI: https://doi.org/10.5588/ijtld.24.0029
Nightingale R, Carlin F, Meghji J, et al. Post-TB health and wellbeing. Int J Tuberc Lung Dis 2023;27:248-83.
DOI: https://doi.org/10.5588/ijtld.22.0514
McDonald AK, Nakkonde D, Kaggwa P, et al. Prevalence of TB-related symptoms and self-reported disability among adult TB survivors. IJTLD Open 2024;1:540-6.
DOI: https://doi.org/10.5588/ijtldopen.24.0141
Pontali E, Silva DR, Marx FM, et al. Breathing back better! A state of the art on the benefits of functional evaluation and rehabilitation of post-tuberculosis and post-COVID lungs. Arch Bronconeumol 2022;58:754-63.
DOI: https://doi.org/10.1016/j.arbres.2022.05.010
Thomson H, Baines N, Huisamen T, et al. A new understanding of clinical patterns in post-TB lung disease. Int J Tuberc Lung Dis 2024;28:115-21.
DOI: https://doi.org/10.5588/ijtld.23.0327
Hoole AS, Ilyas A, Munawar S, et al. Post-TB bronchiectasis: clinical characteristics and microbiology. Int J Tuberc Lung Dis 2024;28:405-6.
DOI: https://doi.org/10.5588/ijtld.24.0151
Martinez-Garcia MA, Guan WJ, de-La-Rosa D, et al. Post-TB bronchiectasis: from pathogenesis to rehabilitation. Int J Tuberc Lung Dis 2023;27:175-81.
DOI: https://doi.org/10.5588/ijtld.22.0566
WHO. Policy brief on tuberculosis-associated disability; 2023. Available from: https://www.who.int/publications/i/item/9789240077799.
Silva DR, Mello FCQ, Galvão TS, et al. Pulmonary rehabilitation in patients with post-tuberculosis lung disease: a prospective multicentre study. Arch Bronconeumol 2025. DOI: 10.1016/j.arbres.2025.02.007.
DOI: https://doi.org/10.1016/j.arbres.2025.02.007
Silva DR, Pontali E, Kherabi Y, et al. Post-TB lung disease: where are we to respond to this priority? Arch Bronconeumol 2025. DOI: 10.1016/j.arbres.2025.03.001.
DOI: https://doi.org/10.1016/j.arbres.2025.03.001
Silva DR, Santos AP, Visca D, et al. The potential for vaccines to aid the treatment of post-TB lung disease. Int J Tuberc Lung Dis 2024;28:111-2.
DOI: https://doi.org/10.5588/ijtld.23.0524
How to Cite
Migliori, Giovanni Battista, Rosella Centis, Lia D’Ambrosio, Dina Visca, Onno W. Akkerman, Denise Rossato Silva, Daria Podlekareva, and Yousra Kherabi. 2025. “Post-Tuberculosis Lung Disease Patients Benefit from Vaccinations As Other Respiratory Conditions”. Monaldi Archives for Chest Disease, May. https://doi.org/10.4081/monaldi.2025.3525.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
